$48.6 Million is the total value of UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's 30 reported holdings in Q4 2015. The portfolio turnover from Q3 2015 to Q4 2015 was 90.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ZIOP | Sell | ZIOPHARM ONCOLOGY INC | $20,805,000 | -80.9% | 2,503,575 | -79.2% | 42.80% | -19.9% |
| WPZ | WILLIAMS PARTNERS LPlp - public equity | $4,811,000 | -12.7% | 172,732 | 0.0% | 9.90% | +265.1% | |
| BPTH | BIO-PATH HOLDINGS INC | $4,750,000 | +8.8% | 3,830,882 | 0.0% | 9.77% | +355.1% | |
| VOO | Sell | VANGUARD 500 INDEX FUNDetfs | $2,794,000 | +4.1% | 14,948 | -2.2% | 5.75% | +335.4% |
| VEA | Sell | VANGUARD FTSE DEV MKTSetfs | $2,789,000 | +1.0% | 75,947 | -2.0% | 5.74% | +322.5% |
| VOE | Sell | VANGUARD MID-CAP VALUE ETFetfs | $2,706,000 | +2.0% | 31,481 | -1.3% | 5.57% | +326.5% |
| VWO | Sell | VANGUARD MSCI EMERGING MKTSetfs | $2,660,000 | -3.2% | 81,323 | -2.1% | 5.47% | +305.0% |
| VDE | Sell | VANGUARD ENERGY ETFetfs | $2,052,000 | -4.0% | 24,690 | -2.1% | 4.22% | +301.6% |
| TXN | TEXAS INSTRUMENTS INC | $1,754,000 | +10.7% | 32,000 | 0.0% | 3.61% | +363.2% | |
| VNQ | Sell | VANGUARD REIT ETFetfs | $1,426,000 | +3.9% | 17,885 | -1.5% | 2.93% | +334.5% |
| GMOLQ | GENERAL MOLY INC | $585,000 | -30.7% | 2,922,831 | 0.0% | 1.20% | +189.9% | |
| BMY | New | BRISTOL-MYERS SQUIBB CO. | $494,000 | – | 7,180 | +100.0% | 1.02% | – |
| LXRX | LEXICON PHARMACEUTICALS INC | $475,000 | +23.7% | 35,714 | 0.0% | 0.98% | +416.9% | |
| ARWR | ARROWHEAD RESEARCH CORP | $220,000 | +6.8% | 35,817 | 0.0% | 0.45% | +348.5% | |
| CSV | New | CARRIAGE SERVICES INC. | $110,000 | – | 4,556 | +100.0% | 0.23% | – |
| AAPL | New | APPLE INC | $51,000 | – | 481 | +100.0% | 0.10% | – |
| PX | New | PRAXAIR INC | $41,000 | – | 400 | +100.0% | 0.08% | – |
| IWP | New | ISHARES TR RUSSELL MIDCAP GROWTH INDetfs | $20,000 | – | 215 | +100.0% | 0.04% | – |
| MSFT | New | MICROSOFT CORP | $13,000 | – | 235 | +100.0% | 0.03% | – |
| COP | New | CONOCOPHILLIPS | $11,000 | – | 228 | +100.0% | 0.02% | – |
| AMP | New | AMERIPRISE FINANCIAL INC | $10,000 | – | 93 | +100.0% | 0.02% | – |
| PSX | New | PHILLIPS 66 | $9,000 | – | 114 | +100.0% | 0.02% | – |
| LUV | New | SOUTHWEST AIRLINES CO | $9,000 | – | 200 | +100.0% | 0.02% | – |
| POR | PORTLAND GENERAL ELECTRIC CO | $4,000 | 0.0% | 118 | 0.0% | 0.01% | +300.0% | |
| ESRX | New | EXPRESS SCRIPTS HLDG | $3,000 | – | 38 | +100.0% | 0.01% | – |
| XOM | Sell | EXXON MOBIL CORP | $3,000 | -62.5% | 34 | -69.1% | 0.01% | +50.0% |
| EFX | EQUIFAX INC. | $3,000 | 0.0% | 29 | 0.0% | 0.01% | +500.0% | |
| ZTS | New | ZOETIS INC | $2,000 | – | 32 | +100.0% | 0.00% | – |
| CST | New | CST BRANDS INC | $2,000 | – | 55 | +100.0% | 0.00% | – |
| GOOG | New | ALPHABET INC CL C | $1,000 | – | 1 | +100.0% | 0.00% | – |
| RJF | Exit | RAYMOND JAMES FINANCIAL INC | $0 | – | -21 | -100.0% | 0.00% | – |
| PFE | Exit | PFIZER INC | $0 | – | -100 | -100.0% | -0.00% | – |
| IBM | Exit | INTERNATIONAL BUSINESS MACHINES CORP | $0 | – | -120 | -100.0% | -0.01% | – |
| KMI | Exit | KINDER MORGAN INC/DE | $0 | – | -1,912 | -100.0% | -0.03% | – |
| SAGE | Exit | SAGE THERAPEUTICS INC | $0 | – | -13,018 | -100.0% | -0.27% | – |
| XON | Exit | INTREXON CORPORATION | $0 | – | -2,100,085 | -100.0% | -32.84% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-02-05
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TEXAS INSTRUMENTS INC | 41 | Q3 2023 | 31.2% |
| PORTLAND GENERAL ELECTRIC CO | 38 | Q3 2023 | 0.0% |
| LEXICON PHARMACEUTICALS INC | 33 | Q3 2023 | 1.7% |
| AEGLEA BIOTHERAPEUTICS INC | 27 | Q2 2023 | 11.0% |
| APOLLO ENDOSURGERY INC | 24 | Q1 2023 | 5.6% |
| PLX PHARMA INC | 23 | Q1 2023 | 1.7% |
| VANGUARD MSCI EMERGING MKTS | 22 | Q2 2019 | 10.3% |
| VANGUARD ENERGY ETF | 22 | Q2 2019 | 8.7% |
| VANGUARD S&P 500 ETF | 21 | Q3 2023 | 11.8% |
| VANGUARD MSCI EAFE ETF | 20 | Q2 2019 | 13.1% |
View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Taysha Gene Therapies, Inc. | September 24, 2021 | 1,156,255 | 3.0% |
| ZIOPHARM ONCOLOGY INC | February 12, 2016 | 9 | 0.0% |
View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-05-01 |
| 3 | 2024-04-30 |
| 13F-HR | 2024-04-30 |
| 144 | 2024-04-29 |
| SC 13G | 2024-03-05 |
| 13F-HR | 2024-02-28 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2023-11-09 |
| 13F-HR | 2023-08-04 |
| 3 | 2023-06-02 |
View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.